MyHep All Tablet (Sofosbuvir + Velpatasvir): Antiviral Tablet | For Chronic Hepatitis C Treatment, Pan-Genotypic HCV Management
MyHep All Tablet contains two antiviral medicines, sofosbuvir and velpatasvir, used together to treat chronic hepatitis C virus (HCV) infection. They work by blocking specific proteins the virus needs to multiply, helping reduce the viral load and clear the infection. The treatment duration and dosage depend on individual medical factors and should be followed as prescribed by a healthcare professional.
Product Overview
MyHep All Tablet contains two active ingredients: Sofosbuvir and Velpatasvir. It is an antiviral medicine used to treat chronic Hepatitis C infection. These ingredients work together to stop the virus from multiplying and spreading in the body, helping the immune system clear the infection. The combination is effective against different genotypes of the Hepatitis C virus (HCV) and is generally prescribed as part of a complete treatment plan.
How Does MyHep All Tablet Work? (Pharmacodynamics)
Both ingredients target different proteins that the Hepatitis C virus needs to multiply:
Sofosbuvir: Blocks the NS5B polymerase enzyme, which the virus uses to make copies of its genetic material. This prevents the virus from multiplying.
Velpatasvir: Blocks the NS5A protein, which plays an important role in viral replication and the formation of new virus particles.
Together, these ingredients interfere with the virus at two different stages, helping reduce the viral load and eliminate the infection.
Understanding Its Role in the Body
MyHep All Tablet works directly against the Hepatitis C virus rather than simply controlling its symptoms. As the amount of virus decreases, the liver gets an opportunity to recover from ongoing infection-related damage. Completing the full prescribed treatment is important for achieving the best possible outcome.
Understanding Its Composition
| Ingredient | Category | Role in the Body |
|---|---|---|
| Sofosbuvir | Antiviral (NS5B polymerase inhibitor) | Prevents the virus from copying its genetic material. |
| Velpatasvir | Antiviral (NS5A inhibitor) | Interferes with viral replication and the formation of new virus particles. |
Expected Results
The treatment aims to achieve a sustained virologic response (SVR), meaning the Hepatitis C virus remains undetectable in the blood 12 weeks after completing treatment. Many patients achieve this outcome with the prescribed combination, although results may vary depending on liver health, previous treatment, and other medical factors.
Pharmacokinetics: How the Body Processes It
After taking MyHep All Tablet, both ingredients are absorbed and processed by the body:
Absorption: Sofosbuvir and velpatasvir are absorbed through the digestive system.
Processing: Sofosbuvir is converted into its active form inside the body, while velpatasvir is mainly processed by the liver.
Elimination: Sofosbuvir-related breakdown products are mainly removed through urine, while velpatasvir is primarily eliminated through faeces.
Clinical Considerations
Missed doses: Take the medicine regularly at the prescribed time. Ask your healthcare professional what to do if you miss a dose.
Medicine interactions: Antacids, acid-reducing medicines, rifampicin, certain anticonvulsants, and some herbal products may affect treatment.
Hepatitis B: Screening for Hepatitis B is important before starting treatment because reactivation can occur during or after Hepatitis C treatment.
Existing conditions: Inform your doctor about liver or kidney problems and any previous Hepatitis C treatment.
Heart medicines: Patients taking amiodarone require special medical attention because combining it with sofosbuvir-containing treatment may cause serious slowing of the heart rate.
Treatment completion: Do not stop the medicine early, even if you feel better. Follow the complete prescribed course.
Storage Instructions
Store MyHep All Tablets in their original packaging in a cool, dry place, away from direct sunlight, heat, and moisture. Keep them out of reach of children and follow the storage instructions on the product packaging.
Summary
MyHep All Tablet combines sofosbuvir and velpatasvir to target two important proteins involved in Hepatitis C virus replication. By blocking viral multiplication, it helps the body clear the infection and achieve a sustained treatment response. Take it exactly as prescribed and complete the full course for the best possible results.
Precautions
MyHep All Tablet (Sofosbuvir + Velpatasvir) requires careful use, particularly in people with liver problems, kidney conditions, or other ongoing treatments. Certain medicines can affect how well its ingredients work, while some combinations may increase the risk of unwanted effects. Follow your doctor's instructions and discuss your medical history before starting treatment.
Before You Start
Discuss liver conditions: Inform your doctor if you have cirrhosis, advanced liver disease, or any previous liver complications.
Check kidney function: Tell your doctor if you have kidney problems, especially severe kidney impairment.
Mention other medicines: Share details of all medicines and supplements you take, particularly antacids, acid-reducing medicines, and heart medications.
Discuss previous hepatitis C treatment: Inform your doctor about any previous antiviral treatment.
Pregnancy and breastfeeding: Discuss the suitability of treatment with your doctor, particularly if ribavirin is also prescribed.
While Using It
Follow the prescribed dose: Take MyHep All exactly as directed and avoid changing the dose yourself.
Take it regularly: Try to take the tablet at the same time each day.
Be careful with antacids: Some medicines that reduce stomach acid can affect velpatasvir absorption. Follow your doctor's instructions about timing.
Avoid unapproved medicines: Do not start herbal products or other medicines without checking for possible interactions.
Attend regular checkups: Your doctor may monitor liver function and treatment response.
Do not stop treatment early: Complete the prescribed course, even if you start feeling better.
When to Seek Medical Help
Slow heartbeat: Seek immediate medical attention if you experience an unusually slow heartbeat, dizziness, fainting, or shortness of breath, especially if taking amiodarone.
Liver-related symptoms: Report yellowing of the skin or eyes, dark urine, or unusual abdominal swelling.
Allergic reactions: Seek medical help for facial swelling, widespread rash, or difficulty breathing.
Unusual weakness: Report persistent tiredness, severe nausea, or other unexpected symptoms.
Note:
MyHep All Tablet should be used under medical supervision. Patients with current or previous hepatitis B infection may require monitoring because hepatitis B can become active again during hepatitis C treatment. Do not stop or change your treatment without consulting your doctor.
Usage
Follow the prescribed schedule: Take MyHep All Tablet (Sofosbuvir + Velpatasvir) exactly as advised by your doctor. It is generally taken once daily, with or without food.
Take it at a regular time: Try to take the tablet at the same time every day to maintain a consistent routine and avoid missing doses.
Missed a dose? If you remember within 18 hours, take it as soon as possible. If more than 18 hours have passed, skip the missed dose and take the next one at your usual time. Do not double the dose.
Check other medicines: Inform your doctor about all medicines and supplements you take, particularly antacids, acid-reducing medicines, and certain medicines used for seizures, tuberculosis, or heart conditions, as they may affect treatment.
Discuss existing health conditions: Tell your doctor if you have kidney or liver problems, especially a history of advanced liver disease, or if you have previously received treatment for hepatitis C.
Monitor your response: Attend recommended blood tests and follow-up appointments so your doctor can check how well the treatment is working.
Uses
MyHep All Tablet contains Sofosbuvir and Velpatasvir, two antiviral ingredients that work together to treat chronic hepatitis C infection. They target different proteins involved in the hepatitis C virus's multiplication process, helping stop the virus from making copies of itself.
Treatment of hepatitis C: Used to treat chronic hepatitis C infection in adults and eligible children, depending on the prescribed regimen.
Controls viral multiplication: Sofosbuvir blocks a viral enzyme needed to copy the virus's genetic material.
Prevents viral replication: Velpatasvir blocks a viral protein called NS5A, which plays an important role in viral multiplication.
Broad genotype coverage: The combination is effective against all major hepatitis C genotypes when used in an appropriate treatment regimen.
Supports liver health: By helping clear the virus, treatment can reduce ongoing liver damage and lower the risk of complications over time.
A Few Things to Remember
Complete the full prescribed treatment course, even if you start feeling better. Do not skip doses or stop taking MyHep All without consulting your doctor. People with hepatitis C may need additional monitoring, particularly if they have advanced liver disease or have previously received antiviral treatment. Regular follow-ups help confirm the treatment response and assess liver health.
Side Effects
MyHep All Tablet contains sofosbuvir and velpatasvir, a combination of antiviral medicines used to treat chronic hepatitis C infection. Like other medicines, it may cause side effects in some people. These effects are generally manageable, but individual responses can vary depending on overall health and other medicines being used.
Common Side Effects
Headache: You may experience mild or occasional headaches.
Fatigue: You may feel unusually tired or have less energy than usual.
Nausea: Some people may experience an uneasy feeling in the stomach.
Weakness: You may feel physically tired or less energetic.
Difficulty sleeping: Some people may experience changes in their sleep pattern.
Diarrhoea: Loose or frequent bowel movements may occur.
Serious Side Effects
Hepatitis B reactivation: Previous or existing hepatitis B infection may become active again during or after hepatitis C treatment.
Slow heartbeat: An unusually slow heart rate may occur, particularly when taken with amiodarone.
Severe allergic reactions: Skin rash, facial or throat swelling, or difficulty breathing requires immediate medical attention.
Liver-related symptoms: Yellowing of the skin or eyes, dark urine, or unusual abdominal discomfort should be reported to a doctor.
Severe weakness or dizziness: Persistent or unusual symptoms require prompt medical assessment.
Note: Take MyHep All Tablet exactly as prescribed and complete the recommended treatment course. Inform your doctor about any history of hepatitis B and all other medicines you take, especially amiodarone. Do not stop treatment without medical advice. Seek medical attention if side effects persist or worsen.
FAQs
1. What is MyHep All Tablet used for?
MyHep All Tablet contains sofosbuvir and velpatasvir. It is used to treat chronic hepatitis C infection in adults and certain children, depending on their age and medical condition.
2. How does MyHep All Tablet work?
It works by blocking proteins that the hepatitis C virus needs to multiply and spread, helping reduce the amount of virus in the body.
3. How should MyHep All Tablet be taken?
Take the tablet exactly as prescribed by your doctor, usually once daily. Swallow it whole with water, with or without food.
4. How long does MyHep All treatment usually last?
Treatment commonly lasts 12 weeks, although the duration may vary depending on the patient's liver condition, previous treatment, and medical history.
5. What are the common side effects of MyHep All Tablet?
Common side effects may include headache, tiredness, nausea, and difficulty sleeping. Contact your doctor if these effects persist or become troublesome.
6. Can MyHep All Tablet completely cure hepatitis C?
Many patients achieve a sustained virological response (SVR), meaning the virus is no longer detectable in their blood 12 weeks after completing treatment. This is generally considered a cure.
7. Can I stop taking MyHep All Tablet once I feel better?
No. Feeling better does not necessarily mean the infection has cleared. Complete the prescribed treatment course to give the medicine the best chance of working.
8. Can MyHep All Tablet be taken with other medicines?
Some medicines can interact with sofosbuvir and velpatasvir, including certain antacids, acid-reducing medicines, rifampicin, and some seizure medicines. Inform your doctor about all medicines and supplements you take.
9. What should I do if I miss a dose of MyHep All Tablet?
If you remember within 18 hours of your usual dose time, take the missed dose as soon as possible. If more than 18 hours have passed, skip it and take the next dose at the regular time. Do not double the dose.
10. Is regular monitoring necessary during MyHep All treatment?
Yes. Your doctor may recommend blood tests to monitor treatment progress and liver function. People with a history of hepatitis B infection may also need monitoring because hepatitis B can reactivate during hepatitis C treatment.
Interactions
MyHep All Tablet contains sofosbuvir and velpatasvir, and certain medicines can affect how these ingredients work in the body. Some combinations may reduce the medicine's effectiveness or increase the risk of side effects. Before starting treatment, tell your healthcare professional about all prescription medicines, over-the-counter products, and supplements you take.
1. Antacids
Medicines used for acidity, such as aluminium or magnesium-containing antacids, may affect velpatasvir absorption.
Keep an appropriate time gap between these medicines as advised by your healthcare professional.
2. Acid-Reducing Medicines
Medicines such as omeprazole, pantoprazole, and other proton pump inhibitors may reduce velpatasvir levels in the body.
Inform your doctor before using medicines for acidity or acid reflux.
3. Certain Antibiotics
Rifampicin and rifabutin may significantly reduce the levels of MyHep All ingredients, making treatment less effective.
These combinations are generally not recommended.
4. Medicines for Epilepsy
Medicines such as carbamazepine, phenytoin, and phenobarbital may reduce the effectiveness of the treatment.
Tell your healthcare professional if you take medicines for seizures.
5. Certain HIV Medicines
Some HIV medicines, particularly those containing tenofovir disoproxil fumarate, may require additional monitoring when taken with MyHep All.
Your doctor may review your treatment and kidney function.
6. Heart Medicines
Taking amiodarone with sofosbuvir-containing medicines may cause a serious slowing of the heart rate.
Seek medical advice before using these medicines together.
Tips to Avoid Interactions
Share a complete list of your medicines and supplements with your healthcare professional.
Do not start acidity medicines, antibiotics, or herbal products without checking first.
Take MyHep All regularly as prescribed and avoid missing doses.
Never stop or change your hepatitis treatment without medical advice.
| Manufacturer | : | Mylan Pharma, India |
| Equivalent Brand | : | Epclusa |
| Generic Search | : | Sofosbuvir + Velpatasvir |
Latest Products
